Inhaled Nitric Oxide Delivery Systems Market Size

Inhaled Nitric Oxide Delivery Systems Market size is expected to reach USD 3 Billion by the end of 2036, growing at a CAGR of 6% during the forecast period i.e., 2024-2036. In the year 2023, the industry size of inhaled nitric oxide delivery systems was over USD 600 Million. Hospital admission is required in over 50% of patients with asthma. The key factor fuelling the growth of the global market is increased R&D efforts which have led to novel applications for this technology in the healthcare sector. Moreover, the demand for inhaled nitric oxide delivery systemss worldwide is driven by an aging population with reduced lung function.

The market is growing as more and more people are using nitric oxide inhalation, a minimally invasive treatment. In a study conducted in 2020, inhaled nitric oxide has been shown to be effective in treating SARSCoV2 infection. It is also an effective treatment for COVID19 patients, as with conventional medicines. As a result, demand for inhaled nitric oxide delivery systemss increased during the pandemic.